Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94 native protein product blog
Tags: Native Protein; Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94; Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94 native protein;
The Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94 n/a (Catalog #MBS142721) is a Native Protein and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA).Immunological Activity: Serological studies of influenza A virus, immunogen for antibody production. Tested with anti-influenza A monoclonal antibodies in ELISA. Researchers should empirically determine the suitability of the Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Our knowledge of the role of proteins in cellular processes is continually evolving. Most proteins, including Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94 are typically involved in one or more signaling pathways or biological processes. Professionally manufactured recombinant proteins are increasingly becoming essential and commonplace tools for elucidating new knowledge about the role of proteins in both health and disease.
Inactivation: Thimerosal and beta propiolactone treatment.This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.